Belizario, Jose Ernesto 
; Faintuch, Joel; Garay-Malpartida, Humberto Miguel
Source: Mediators of Inflammation. Unidades: FM, EACH
Assunto: DOENÇAS METABÓLICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BELIZARIO, Jose Ernesto e FAINTUCH, Joel e GARAY-MALPARTIDA, Humberto Miguel. Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases. Mediators of Inflammation, v. 2018, p. 01-12, 2018Tradução . . Disponível em: https://doi.org/10.1155/2018/2037838. Acesso em: 26 jul. 2024.APA
Belizario, J. E., Faintuch, J., & Garay-Malpartida, H. M. (2018). Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases. Mediators of Inflammation, 2018, 01-12. doi:10.1155/2018/2037838NLM
Belizario JE, Faintuch J, Garay-Malpartida HM. Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases [Internet]. Mediators of Inflammation. 2018 ; 2018 01-12.[citado 2024 jul. 26 ] Available from: https://doi.org/10.1155/2018/2037838Vancouver
Belizario JE, Faintuch J, Garay-Malpartida HM. Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases [Internet]. Mediators of Inflammation. 2018 ; 2018 01-12.[citado 2024 jul. 26 ] Available from: https://doi.org/10.1155/2018/2037838
